These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

478 related articles for article (PubMed ID: 36986776)

  • 1. Photobiomodulation in Alzheimer's Disease-A Complementary Method to State-of-the-Art Pharmaceutical Formulations and Nanomedicine?
    Ailioaie LM; Ailioaie C; Litscher G
    Pharmaceutics; 2023 Mar; 15(3):. PubMed ID: 36986776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional nanoassemblies for the diagnosis and therapy of Alzheimer's diseases.
    Zhang L; Sun H; Chen Y; Wei M; Lee J; Li F; Ling D
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 Jul; 13(4):e1696. PubMed ID: 33463089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advancements in the Application of Nanomedicine in Alzheimer's Disease: A Therapeutic Perspective.
    Puranik N; Yadav D; Song M
    Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Photobiomodulation in experimental models of Alzheimer's disease: state-of-the-art and translational perspectives.
    Huang Z; Hamblin MR; Zhang Q
    Alzheimers Res Ther; 2024 May; 16(1):114. PubMed ID: 38773642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanomedicines in the Management of Alzheimer's Disease: Current View and Future Prospects.
    Chopra H; Bibi S; Singh I; Kamal MA; Islam F; Alhumaydhi FA; Emran TB; Cavalu S
    Front Aging Neurosci; 2022; 14():879114. PubMed ID: 35875806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functionalization strategies of polymeric nanoparticles for drug delivery in Alzheimer's disease: Current trends and future perspectives.
    La Barbera L; Mauri E; D'Amelio M; Gori M
    Front Neurosci; 2022; 16():939855. PubMed ID: 35992936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic Nanomedicine: Photodynamic, Photothermal and Photoimmune Therapy in Hepatocellular Carcinoma: Fulfilling the Myth of Prometheus?
    Ailioaie LM; Ailioaie C; Litscher G
    Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37176014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanomedicine Strategies for Sustained, Controlled and Targeted Treatment of Alzheimer's Disease.
    Ma TJ; Gao J; Liu Y; Zhuang JH; Yin C; Li P; Mao L; Xu J; Xu YX; Li YP; Zhao ZX; Yin Y
    Mini Rev Med Chem; 2018; 18(12):1035-1046. PubMed ID: 29243575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic non-invasive brain treatments in Alzheimer's disease: recent advances and challenges.
    Wu C; Yang L; Feng S; Zhu L; Yang L; Liu TC; Duan R
    Inflamm Regen; 2022 Oct; 42(1):31. PubMed ID: 36184623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advancements in nanotherapeutics for Alzheimer's disease: current perspectives.
    Harilal S; Jose J; Parambi DGT; Kumar R; Mathew GE; Uddin MS; Kim H; Mathew B
    J Pharm Pharmacol; 2019 Sep; 71(9):1370-1383. PubMed ID: 31304982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of phototherapy of Alzheimer's disease during sleep and wakefulness: the role of the meningeal lymphatics.
    Oxana SG; Alexander S; Inna B; Ivan F; Andrey T; Alexander D; Maria T; Daria E; Viktoria A; Arina E; Valeria T; Anna T; Valeria K; Maria M; Alexander D; Thomas P; Jürgen K
    Front Optoelectron; 2023 Sep; 16(1):22. PubMed ID: 37721564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Photobiomodulation for Alzheimer's Disease: Has the Light Dawned?
    Hamblin MR
    Photonics; 2019 Sep; 6(3):. PubMed ID: 31363464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of Neurodegeneration: Integrating Photobiomodulation and Neurofeedback in Alzheimer's Dementia and Parkinson's: A Review.
    Berman MH; Nichols TW
    Photobiomodul Photomed Laser Surg; 2019 Oct; 37(10):623-634. PubMed ID: 31647776
    [No Abstract]   [Full Text] [Related]  

  • 14. Recent Mechanisms of Neurodegeneration and Photobiomodulation in the Context of Alzheimer's Disease.
    Su M; Nizamutdinov D; Liu H; Huang JH
    Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurotherapeutic applications of nanomedicine for treating Alzheimer's disease.
    Wilson B; Geetha KM
    J Control Release; 2020 Sep; 325():25-37. PubMed ID: 32473177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent Advances in Nanotherapeutic Interventions for the Treatment of Alzheimer's Disease.
    Dogra A; Narang RS; Narang JK
    Curr Pharm Des; 2020; 26(19):2257-2279. PubMed ID: 32321393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanocarrier mediated drug delivery as an impeccable therapeutic approach against Alzheimer's disease.
    Taliyan R; Kakoty V; Sarathlal KC; Kharavtekar SS; Karennanavar CR; Choudhary YK; Singhvi G; Riadi Y; Dubey SK; Kesharwani P
    J Control Release; 2022 Mar; 343():528-550. PubMed ID: 35114208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanotherapeutics for Alzheimer's Disease with Preclinical Evaluation and Clinical Trials: Challenges, Promises and Limitations.
    Bukhari SNA
    Curr Drug Deliv; 2022; 19(1):17-31. PubMed ID: 34514990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical Discoveries on Multi-Target Approach to Manage Alzheimer's Disease.
    Batool A; Kamal MA; Rizvi SMD; Rashid S
    Curr Drug Metab; 2018; 19(8):704-713. PubMed ID: 29512457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanomedicine in Alzheimer's disease: Amyloid beta targeting strategy.
    Tosi G; Pederzoli F; Belletti D; Vandelli MA; Forni F; Duskey JT; Ruozi B
    Prog Brain Res; 2019; 245():57-88. PubMed ID: 30961872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.